UNIGE document Scientific Article
previous document  unige:76220  next document
add to browser collection
Title

Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review

Authors
Peytavin, G
Published in New microbes and new infections. 2015, vol. 6, p. 1-4
Abstract The management of multidrug-resistant human immunodeficiency virus (MDR HIV) infections in children is particularly challenging due to the lack of experience with new drugs. Dolutegravir, combined with an optimized antiretroviral background therapy, is promising for the treatment of MDR HIV and has been approved recently for adults and adolescents. Data for children are extremely limited. We describe the efficacy, safety and plasmatic levels of a dolutegravir-based, complex active antiretroviral treatment regimen in a severely overweight 11-year-old child infected with an MDR HIV strain.
Identifiers
PMID: 26082840
Full text
Article (Published version) (237 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Groupe Posfay-Barbe Clara (pédiatrie générale) (853)
Groupe Desmeules Jules (pharmacologie/toxicologie) (567)
Citation
(ISO format)
WAGNER, Noémie et al. Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review. In: New Microbes and New Infections, 2015, vol. 6, p. 1-4. https://archive-ouverte.unige.ch/unige:76220

131 hits

1 download

Update

Deposited on : 2015-10-16

Export document
Format :
Citation style :